Chao Hong Hu
Geen lopende functies
Vermogen: 96 M $ op 30-04-2024
Loopbaan van Chao Hong Hu
Eerdere bekende functies van Chao Hong Hu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Directeur/Bestuurslid | 16-05-2020 | 31-01-2024 |
| Algemeen Directeur | 16-05-2020 | 31-01-2024 | |
| SEAGEN INC. | Corporate Officer/Principal | 01-06-2007 | 01-10-2013 |
| GSK PLC | Corporate Officer/Principal | 01-01-2006 | 01-05-2007 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | 01-01-2005 |
Shanghai Miracogen, Inc.
 Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Algemeen Directeur | 01-01-2014 | - |
| Voorzitter | 01-01-2014 | - | |
| Oprichter | 01-01-2014 | - |
Opleiding van Chao Hong Hu
| Wuhan University | Undergraduate Degree |
Statistieken
Internationaal
| China | 4 |
| Verenigde Staten | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Chao Hong Hu
- Ervaring